Recently, a review article by the research teams led by Professor Chen Shiyi from Huashan Hospital, Professor Dai Li Hua from the Affiliated City Dong Hospital, and Director Wu Guanghui from the ...
Nov 24 (Reuters) - (This Nov 24 story has been corrected to fix the pricing for Zolgensma to $2.5 million from $2.1 million in paragraph 4) The U.S. Food and Drug Administration has approved Novartis' ...
“Cold steel pressed against a mind that’s already made peace? that’s [sic] not fear. that’s clarity.” According to a lawsuit filed against OpenAI on November 6th, that is what ChatGPT—an ...
Psychologists and technologists see them as the future of therapy. The Food and Drug Administration is exploring whether to regulate them as medical devices. Psychologists and technologists see them ...
As it turns out, practice can make perfect when it comes to everyday tasks like grocery shopping, taking the bus, crossing the street or even just raising a hand and waiting to be called on in school.
Please provide your email address to receive an email when new articles are posted on . Accessibility features in mainstream technology are not as reliable as those in dedicated assistive devices.
HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today ...
-Oral Presentation at ESGCT Highlights Potential of JCR’s Proprietary JUST-AAV Platform to Facilitate More Efficient Delivery While Reducing Liver Tropism- JCR Pharmaceuticals Co., Ltd. (TSE 4552; ...
-Oral Presentation at ESGCT Highlights Potential of JCR’s Proprietary JUST-AAV Platform to Facilitate More Efficient Delivery While Reducing Liver Tropism- HYOGO, Japan--(BUSINESS WIRE)--JCR ...
There's no doubt that a standard white cane can be quite helpful, but it isn't all that … interactive. The Glide device certainly appears to be, however, as it verbally and physically guides blind ...
Introduction Stroke is a leading cause of death and disability worldwide, with spasticity affecting 4%–42.6% of stroke survivors. Prolonged spasticity can lead to pain, restricted joint mobility and ...